N Engl J Med 313 : 709715
[DOI] [PMC free article] [PubMed] [Google Scholar] 74.European Medicines Agency
Journal of Cellular Physiology, 234 (5), 57865797
Nicola Magrini, Unit head for Innovation, Evidence synthesis and Clinical research, University Hospital, Bologna, Italy, Co-Chair of the Guidelines Development Group Comments: GLP-1 and inclusion in the essential medicine Mr Deus Mubangizi, Director, Medicines and Health Products Policies and Standards Department, WHO Panel discussion Ms Jeanette Hunter General Primary Health Care at the National Department of Health (NDoH) of South Africa, and Co-Chair of the Guidelines Development Group
If a provider publishes processing timeframes and verification steps up front, that is a positive signal